Overview

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML

Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
This study compared treatment groups of patients treated with vosaroxin and cytarabine versus patients treated with placebo and cytarabine.
Phase:
Phase 3
Details
Lead Sponsor:
Sunesis Pharmaceuticals
Treatments:
Cytarabine